title: Is switching protease inhibitor-based effective antiretroviral therapy safe in patients with AIDS-associated Kaposi's sarcoma?
authors.forename: Anna Lisa
authors.initials: AL
authors.lastname: Ridolfo
authors.forename: Mario
authors.initials: M
authors.lastname: Corbellino
authors.forename: Nicoletta
authors.initials: N
authors.lastname: Tosca
authors.forename: Anna
authors.initials: A
authors.lastname: Capelletti
authors.forename: Chiara
authors.initials: C
authors.lastname: Scalamogna
authors.forename: Massimo
authors.initials: M
authors.lastname: Galli
authors.forename: Carlo
authors.initials: C
authors.lastname: Parravicini
mesh_terms: D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy*; D023241:Antiretroviral Therapy, Highly Active / Q000379:methods*; D017320:HIV Protease Inhibitors / Q000627:therapeutic use*; D006801:Humans; D012008:Recurrence; D012514:Sarcoma, Kaposi / Q000188:drug therapy*; D016896:Treatment Outcome
chemical_list: D017320:HIV Protease Inhibitors